dobutamine has been researched along with Adverse Drug Event in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Aqel, B; McCully, R; Olson, N; Pellikka, P; Shipman, J; Snipelisky, D; Watt, K | 1 |
Abdelali, S; Abir, S; Berrada, A; Chaara, A; Cherradi, R; Cherti, M; Doghmi, N; Elhajjaji, I; Ellouali, F; Fennich, N | 1 |
Askew, JW; Klarich, KW; McCully, RB; Pellikka, PA; Scott, CG; Sheldon, SH | 1 |
6 other study(ies) available for dobutamine and Adverse Drug Event
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Low to Intermediate Dose Atropine Administration During Dobutamine Stress Echocardiography in the Pre-Liver Transplant Population.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atropine; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Echocardiography, Stress; End Stage Liver Disease; Female; Humans; Liver Transplantation; Male; Middle Aged; Preoperative Care; Prospective Studies | 2018 |
Stress echocardiography: safety and tolerability.
Topics: Arrhythmias, Cardiac; Comorbidity; Coronary Artery Disease; Dobutamine; Drug-Related Side Effects and Adverse Reactions; Echocardiography; Exercise Test; Female; Humans; Incidence; Male; Middle Aged; Morocco; Prognosis; Risk Assessment; Vasodilator Agents | 2013 |
Occurrence of atrial fibrillation during dobutamine stress echocardiography: incidence, risk factors, and outcomes.
Topics: Aged; Atrial Fibrillation; Comorbidity; Coronary Artery Disease; Dobutamine; Drug-Related Side Effects and Adverse Reactions; Echocardiography; Exercise Test; Female; Humans; Incidence; Male; Minnesota; Risk Assessment; Risk Factors; Vasodilator Agents | 2011 |